When was Sequence Bio founded?

Sequence Bio was founded in 2013 and raised its 1st funding round 2 years after it was founded.

Where is Sequence Bio located?

Sequence Bio is headquartered in St John s, Canada.

How many employees does Sequence Bio have?

As of Jun 30, 2026, the latest employee count at Sequence Bio is 19.

Is Sequence Bio a funded company?

Sequence Bio is a funded company, having raised a total of $5.47M across 4 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Oct 19, 2015.

When was the latest funding round of Sequence Bio?

Sequence Bio's latest funding was a $***** Seed round on Jul 30, 2019, with participation from 0 investor.

Where does Sequence Bio rank among its competitors?

Sequence Bio ranks 26th amongst 662 active competitors, of which 76 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was SeqOne, which secured $22.7M in May, 2025.

Who are the top competitors of Sequence Bio?

Sequence Bio's top competitors include Tessera Therapeutics, BGI and Hexagon Bio. Among them, SeqOne secured the most recent funding round in May, 2025.

Sequence Bio - 2026 Company Profile, Funding & Competitors

Company Details

Sequence Bio is a data-driven biotechnology company based in Newfoundland and Labrador, Canada leading a 100,000 person genome sequencing project.

Website: www.sequencebio.com/
Social
Email ID: *****@sequencebio.com
Phone Number: +1 **********

Key Metrics

Founded Year

2013

Location

St John s, Canada

Stage

Seed

Total Funding

$5.47M in 4 rounds

Latest Funding Round

Seed, Jul 30, 2019, $*****

Investors

Y Combinator & 6 more

Ranked

26^th among 662 active competitors

Employee Count

19 as on Jun 30, 2026

Similar Companies

Singular Genomics & 395 more

View Sequence Bio's full profile

Sequence Bio has raised a total funding of $5.47M over 4 rounds. Its first funding round was on Oct 19, 2015. Sequence Bio has 7 institutional investors.

Here is the list of recent funding rounds of Sequence Bio:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 30, 2019	1643435	Seed	5111238	6686151	7007276	9669930
2019	7602	Seed	7416	6222	3559	7548
Jun 28, 2016	7107516	Seed	8536065	6382030	DCVC	Killick Capital & 2 more

Access funding benchmarks and valuations. Sign up today!

View details of Sequence Bio's funding rounds and investors

Sequence Bio's employee count trend

Sequence Bio has 19 employees as of Jun 26. Here is Sequence Bio's employee count trend over the years:

Uncover Sequence Bio's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Sequence Bio include Tessera Therapeutics, BGI and Hexagon Bio. Here is the list of Top 10 competitors of Sequence Bio, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Tessera Therapeutics 2017, Cambridge (United States), Series C	Provider of new genome engineering technology for treating multiple diseases	$610M	T. Rowe Price, ADIA & 22 others	64/100
2nd	BGI 1999, Shenzhen (China), Public	Provider of services in genome sequencing	-	Sequoia Capital China, Yunfeng Capital & 15 others	64/100
3rd	Hexagon Bio 2017, Menlo Park (United States), Series B	Provider of bioinformatics tools for the analysis of microbial genomic sequencing data	$206M	The Column Group, Nextech Invest & 10 others	63/100
4th	Singular Genomics 2016, San Diego (United States), Acquired	Provider of next-generation gene sequencing and multi-omics technologies	-	Perceptive Advisors, Domain Associates & 5 others	60/100
5th	Omniome 2013, San Diego (United States), Acquired	Provider of genome sequencing platform	$160M	Decheng Capital, Hillhouse & 12 others	59/100
6th	Novogene Corporation 2011, Beijing (China), Series B	Provider of genomic services and solutions	$75M	SDIC Innovation, CMB International Capital ... & 4 others	58/100
7th	Replay 2021, San Diego (United States), Acquired	Provider of genomic reprogramming platform for writing and delivering big DNA	$55M	OMX Ventures, KKR & 6 others	58/100
8th	HitGen 2012, Lanzhou (China), Public	Developer of DNA encoded libraries for drug discovery	$39.1M	CDH, Shiyu & 2 others	57/100
9th	SeqOne 2017, Montpellier (France), Series A	Provider of bioinformatics tools for the analysis of genome sequencing data	$48.8M	Supernova Invest, Elaia & 7 others	57/100
10th	Slingshot Bioscience 2012, Berkeley (United States), Series A	Developer of next-generation synthetic cells for diagnostics and therapeutics	$46.4M	Northpond Ventures, Arch Venture Partners ... & 2 others	56/100
26th	Sequence Bio 2013, St John s (Canada), Seed	Sequence Bio is a Newfoundland and Labrador biotechnology company striving to improve how we treat diseases and develop medicines.	$5.47M	Y Combinator, DCVC & 5 others	45/100